Gilead Sciences
GILD
$86.36
Share price
2.20%
Change (1 day)
35.45%
Change (1 year)
Categories
Revenue for Gilead Sciences (GILD)
Revenue in 2022 (TTM): $27.13 B
According to Gilead Sciences's latest financial reports the company's current revenue (TTM) is $27.13 B. In 2021 the company made a revenue of $27.30 B an increase over the years 2020 revenue that were of $24.68 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Revenue history for Gilead Sciences from 2001 to 2022
Annual revenue
| Year | Revenue | Change |
|---|---|---|
| 2022 (TTM) | $27.13 B | -0.62% |
| 2021 | $27.30 B | 10.6% |
| 2020 | $24.68 B | 9.98% |
| 2019 | $22.44 B | 1.46% |
| 2018 | $22.12 B | -15.24% |
| 2017 | $26.10 B | -14.09% |
| 2016 | $30.39 B | -6.89% |
| 2015 | $32.63 B | 31.13% |
| 2014 | $24.89 B | 122.2% |
| 2013 | $11.20 B | 15.45% |
| 2012 | $9.70 B | 15.71% |
| 2011 | $8.38 B | 5.48% |
| 2010 | $7.94 B | 13.38% |
| 2009 | $7.01 B | 31.4% |
| 2008 | $5.33 B | 26.14% |
| 2007 | $4.23 B | 39.78% |
| 2006 | $3.02 B | 49.19% |
| 2005 | $2.02 B | 53.13% |
| 2004 | $1.32 B | 52.63% |
| 2003 | $0.86 B | 85.92% |
| 2002 | $0.46 B | 99.68% |
| 2001 | $0.23 B |
Revenue for similar companies or competitors
| Company | Revenue | Revenue differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $94.94 B | 249.88% | 🇺🇸 USA |
 Pfizer PFE | $99.67 B | 267.32% | 🇺🇸 USA |
 AbbVie ABBV | $57.81 B | 113.07% | 🇺🇸 USA |
 Eli Lilly LLY | $29.23 B | 7.75% | 🇺🇸 USA |
 Amgen AMGN | $26.33 B | -2.97% | 🇺🇸 USA |
 Biogen BIIB | $10.36 B | -61.81% | 🇺🇸 USA |
 Illumina ILMN | $4.69 B | -82.68% | 🇺🇸 USA |
 Vertex Pharmaceuticals VRTX | $8.70 B | -67.94% | 🇺🇸 USA |
 Merck MRK | $58.97 B | 117.33% | 🇺🇸 USA |